$CADL Candel Therapeutics Announces Positive Interim Data from Randomized Phase 2 Clinical Trial of CAN-2409 in Non-Metastatic Pancreatic Cancer https://finance.yahoo.com/news/candel-therapeutics-announces-positive-interim-120000019.html